In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 517-518

  Malay, Sheila ^a   Roblin, Patricia M ^a   Reznik, Tamara ^a   Kutlin, Andrei ^a   Hammerschlag, Margaret R ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; GARENOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; FLUOROQUINOLONES; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0036146753     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.517-518.2002     Document Type: Article

References (11)

1. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin
2. 1998 Guidelines for the treatment of sexually transmitted diseases
3. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
4. In vitro activities of five quinolones against Chlamydia pneumoniae
5. Antimicrobial susceptibility and therapy of infections due to Chlamydia pneumoniae
6. Microbiological efficacy of moxifloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
7. Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: A review
8. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
9. In vitro activity of grepafloxacin against Haemophilus influenzae and Moraxella catarrhalis
10. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community acquired pneumonia
11. In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae